The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains

SETTING: Tartu, Estonia.OBJECTIVE: To assess the performance and feasibility of the introduction of the thin-layer agar MDR/XDR-TB Colour Test (Colour Test) as a non-commercial method of drug susceptibility testing (DST).DESIGN: The Colour Test combines the thin-layer agar technique with a simple co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The international journal of tuberculosis and lung disease 2012-08, Vol.16 (8), p.1113-1118
Hauptverfasser:	Toit, K., Mitchell, S., Balabanova, Y., Evans, C. A., Kummik, T., Nikolayevskyy, V., Drobniewski, F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Bacterial diseases Biological and medical sciences Ciprofloxacin Color Drug Resistance, Multiple, Bacterial Estonia Extensively Drug-Resistant Tuberculosis - diagnosis Extensively Drug-Resistant Tuberculosis - drug therapy Extensively Drug-Resistant Tuberculosis - microbiology Feasibility Studies Fluoroquinolones Human bacterial diseases Humans Infectious diseases Isoniazid Medical sciences Microbial Sensitivity Tests - methods Multidrug-Resistant Tuberculosis Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - growth & development Mycobacterium tuberculosis - isolation & purification Pneumology Predictive Value of Tests Rifampin Sensitivity and Specificity Thin-Layer Agar Time Factors Tuberculosis and atypical mycobacterial infections Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - microbiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!